Global Function Driven Metagenomics Market, By Product (Kits and Reagents, Sequencing and Data Analytics Services, Instruments, Consumables and Others), Application (Environmental, Human Health, Agriculture, Biotechnology, Biofuel and Others), End Users (Pharmaceutical Industries, Biotechnology Companies, Research Laboratories, Pathology Laboratories, Academic and Research Institutes and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Data Bridge Market Research analyses that the function driven metagenomics market will exhibit a CAGR of around 6.89% for the forecast period of 2021-2028. Increasing adoption of next-generation sequencing methods globally, rising expenditure for research and development proficiencies and increasing public and private expenditure for the development of healthcare infrastructure especially in emerging economies are the major factors attributable to the growth of function driven metagenomics market. This means that the market value which was USD 163.60 million in 2020, will rocket up to USD 278.79 million by 2028.
Metagenomics is used for the analysis of DNA samples. Metagenomics helps in understanding the structure and functional potential. In other words, it helps in the study and analysis of microorganisms present in the environment. Therefore, function driven metagenomics is used for high quality analysis of microbes.
Upsurge in the technological advancements in the field of metagenomics is one of the major factors inducing growth in the function driven metagenomics market value. Rising research and development activities will further generate lucrative and remunerative growth opportunities for the function driven metagenomics market. Growing awareness among consumers especially in the developing economies will also act as an important function driven metagenomics market growth determinant. Increasing applications of function-driven metagenomics for understanding gut microbes and genes will also propel growth in the function driven metagenomics market value.
However, lack of infrastructure, instruments and capabilities will derail the function driven metagenomics market growth rate. High costs associated with metagenomics will hamper the function driven metagenomics market growth rate. Also, high capital investment required for research and development activities will also create hindrances for the function driven metagenomics market.
This function driven metagenomics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on function driven metagenomics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Function Driven Metagenomics Market Scope and Market Size
The function driven metagenomics market is segmented on the basis of product, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the global function driven metagenomics market is segmented into kits and reagents, sequencing and data analytics services, instruments, consumables and others. Kits and reagents segment is sub-segmented into library preparation kits, sample extraction kits and metagenomic sequencing kits.
- On the basis of application, the function driven metagenomics market is segmented into environmental, human health, agriculture, biotechnology, biofuel and others. Human health segment is sub-segmented into infectious disease diagnostics and gut microbe characterization. Biotechnology segment is sub-segmented into bio surfactants and antibiotics production, clinical diagnostics and microbial diversity.
- On the basis of end users, the function driven metagenomics market is segmented into pharmaceutical industries, biotechnology companies, research laboratories, pathology laboratories, academic and research institutes and others.
Function Driven Metagenomics Market Country Level Analysis
The function driven metagenomics market is analysed and market size insights and trends are provided by country, product, application and end users as referenced above.
The countries covered in the function driven metagenomics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the function driven metagenomics market owing to the rising public health awareness and a significant rise in environmental degradation. Asia-Pacific on the other hand is projected to undergo the highest growth rate during the forecast period owing to the prevalence of proactive government policies to set up genomic libraries.
The country section of the function driven metagenomics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The function driven metagenomics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for function driven metagenomics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the function driven metagenomics market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Function Driven Metagenomics Market Share Analysis
The function driven metagenomics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to function driven metagenomics market.
The major players covered in the function driven metagenomics market report are Danaher, Merck KGaA, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd, Novogene Corporation, PerkinElmer Inc., Arc Bio, LLC, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Promega Corporation, Takara Bio Inc., IntegraGen, Zymergen, Pacific Biosciences of California, Inc., BGI, Eurofins Scientific, Macrogen Inc. and CD Genomics among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.